Insider Transactions in Q1 2022 at Protara Therapeutics, Inc. (TARA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Luke M Beshar |
BUY
Open market or private purchase
|
Direct |
10,000
+5.05%
|
$40,000
$4.25 P/Share
|
|
Mar 10
2022
|
Luke M Beshar |
BUY
Open market or private purchase
|
Direct |
10,000
+5.32%
|
$40,000
$4.46 P/Share
|
|
Jan 28
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
24,031
+1.96%
|
$96,124
$4.96 P/Share
|
|
Jan 10
2022
|
Jathin Bandari Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jan 10
2022
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,080
-0.58%
|
$30,480
$6.27 P/Share
|
|
Jan 10
2022
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
4,603
-5.51%
|
$27,618
$6.27 P/Share
|
|
Jan 03
2022
|
Blaine Davis Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,100
+47.51%
|
-
|
|
Jan 03
2022
|
Jesse Shefferman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
42,300
+4.6%
|
-
|
|
Jan 03
2022
|
Jacqueline Zummo Chf Scientific Operations Off |
BUY
Grant, award, or other acquisition
|
Direct |
14,100
+14.44%
|
-
|